Dargen 60 Injection
Marketer
Lupin Ltd
Salt Composition
Darbepoetin alfa (60mcg)
Overview Dargen 60 Injection
Dargen 60 Injection treats anemia resulting from chronic kidney disease or chemotherapy. Its mechanism involves stimulating red blood cell production within the bone marrow. Administered under strict medical supervision, this medication carries a risk of significant adverse reactions, necessitating treatment by an experienced physician and meticulous adherence to their instructions. Frequently reported side effects encompass abdominal discomfort, hypertension, skin rashes, injection site pain, dyspnea, cough, and peripheral swelling. Severe headaches, visual disturbances, nausea, vomiting, or convulsions may indicate dangerously elevated blood pressure and require immediate medical attention. Regular blood tests, monitoring electrolyte levels (like potassium), hemoglobin, and blood cell counts, are typically conducted. Discontinue use and seek medical counsel if shortness of breath or a skin eruption develops. Prior to commencing treatment, disclose any history of cardiac disease, hypertension, seizures, or strokes. Pregnant or breastfeeding individuals, or those intending to become pregnant or breastfeed, must consult their physician regarding its suitability.
Uses of Dargen 60 Injection
Managing anemia associated with chronic kidney failure | Addressing anemia caused by cancer treatments
Major Benefits of Dargen 60 Injection:
The medication will be administered by your physician or their associate; self-medication is strictly prohibited.
Common Side effects of Dargen 60 Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Dargen 60 Injection:
This medication will be administered by your physician or their qualified nursing staff; self-medication is strictly prohibited.
How Dargen 60 Injection works:
Dargen 60 Injection is an erythropoietin-based medication that boosts red blood cell production. It acts by prompting the bone marrow, the blood cell-forming tissue within bones, to increase red blood cell output.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dargen 60 Injection presents an unknown safety profile. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Dargen 60 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Dargen 60 Injection while breastfeeding is likely inadvisable. Available data in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Dargen 60 Injection.
KidneySAFE IF PRESCRIBED
Dargen 60 Injection poses no safety concerns for patients with renal impairment; dose modification is unnecessary.
LiverCAUTION
For individuals with hepatic impairment, Dargen 60 Injection requires careful administration. Dosage modification of Dargen 60 Injection might be necessary. Physician consultation is advised.
What if you forget to take Dargen 60 Injection :
Should you forget a Dargen 60 Injection, administer it immediately. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dargen 60 Injection
| Label | Value |
|---|---|
| Chemical Type | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Type of Treatment | KINSHIP |
| Actions | Erythropoietin-stimulating drug |





